Table 1.
Reference | No. of patients | Graft | Conditioning regimen | Anti-retroviral therapy | Effect on HIV | Follow-up |
---|---|---|---|---|---|---|
Hasset et al. (1983) [12] | 2 | MUD | None | – | None | NR |
Lane et al. (1984) [18] | 1 | SYN | None | – | CD4+ increased | Died after 12 months |
Mitsuyasu et al. 1984 [19] | 2 | SYN | 1 × VPL, TBI | – | None | Died day +41 |
Vilmer et al. (1987) [51] | 1 | SYN | NR | – | CD4+ increased | 7 years |
Verdonck et al. (1988) [14] | 1 | SYN | CPM, TBI | – | None | Died after 56 months |
Holland et al. (1989) [24] | 1 | MUD | CPM, TBI | – | PCR negative from day +41, AB declined | Died on day +47 |
Saral & Holland (1994) [25] | 7 | 4 × MUD 3 × SYN | 6 × CPM and TBI 1 × CPM and BSN | – | 1 patient* PCR-negative from days 40–120, 1–2 log decrease in virus titre | *Died later on GVHD 1 patient died < 30 days |
Lane et al. (1990) [26] | 16 | SYN | None | – | None | 10 alive (23·4 ± 4 months), 5 died (17·6 ± 5·5 months) |
Furlini et al. (1988) [15]Bardini et al. (1991) [16] | 1 | MRD | CPM, TBI | – | None | Alive 3 years |
Angelucci et al. (1991) [27] | 1 | MUD | BSN, CPM | – | None | Died on day +263 |
Aboulafia et al. (1991) [28] | 1 | SYN | ETP, BCNU, CPM | – | None | Died on day +52 |
Giri et al. (1992) [29] | 1 | MUD | CPM, ATG, TBI | – | None | Died after 13 months |
Torlontano et al. (1992) [30] | 1 | MUD | BSN, CPM | – | Increased CD4/CD8 ratio | Died on day +48 |
Turner et al. (1992) [65] | 1 | SYN | CPM, TBI | AZT | p24 antigene negative | Died on day +18 |
Contu et al. (1993) [54] | 1 | MUD | BSN, CPM | AZT +IFN-α2 | PCR negative from day +30, anti-HIV-AB negative after 4 months | Died on day +301 |
Campbell et al. (1999) [66] | 1 | SYN | CPM, BCNU, ETP | 3TC, d4T | None | Alive 12 months |
3TC, lamivudine; AB, antibodies; AZT, zidovudine; BCNU, carmustin; BSN, busulphan; CPM, cyclophosphamide; d4T, stavudine; ETP, etoposide; IFN-α2, interferon-alpha2; MRD, matched related donor; MUD, matched unrelated donor; NR, not reported; PCR, polymerase chain reaction; SYN, syngeneic donor; TBI, total body irradiation; VBL, vinblastine.